Literature DB >> 1423954

A randomized comparison of external and internal cardioversion of chronic atrial fibrillation.

S Lévy1, P Lauribe, E Dolla, W Kou, A Kadish, H Calkins, F Pagannelli, C Moyal, M Bremondy, A Schork.   

Abstract

BACKGROUND: Delivery of shocks within the right atrium has been reported to be more effective than conventional external shocks in converting atrial fibrillation (AF), but these two cardioversion techniques have never been compared prospectively. The purpose of this study was to compare the efficacies of external and internal cardioversion in patients with chronic AF unresponsive to prior attempts at electrical and/or pharmacological cardioversion. Low-dose amiodarone was used in all patients after cardioversion to suppress recurrences of AF. METHODS AND
RESULTS: One hundred twelve patients with AF of at least 1 month in duration were randomly assigned to undergo external cardioversion with 300-360-J shocks or internal cardioversion with 200-300-J shocks delivered through a standard electrode catheter within the right atrium. The patients were treated with amiodarone (200 mg/day 5-7 days/week) for 1 month before electrical cardioversion and afterward if the cardioversion was successful. The patients were evaluated at regular intervals during 1 year of follow-up. The efficacy of internal cardioversion was significantly greater than that of external cardioversion (91% versus 67%, p = 0.002). The only variable that was associated with the outcome of cardioversion was body weight. Among patients in whom sinus rhythm was restored, AF recurred as often after internal and external cardioversion; at 1 year of follow-up, 37% of patients in whom external or internal cardioversion had been effective were still in sinus rhythm. Patients who had undergone an attempt at electrical cardioversion before entry into this study were less likely to remain in sinus rhythm after cardioversion. The only complications of cardioversion were one instance of cerebral thromboembolism after external cardioversion and one instance of transient pulmonary edema after internal cardioversion. Therapy with amiodarone was discontinued because of an adverse drug effect in only three patients.
CONCLUSIONS: Internal cardioversion is more effective than external cardioversion in restoring sinus rhythm and is as safe as external cardioversion in patients with chronic AF. The recurrence rate of AF is the same after both types of cardioversion. If conventional electrical cardioversion is ineffective, internal cardioversion should be attempted. The combination of low-dose amiodarone and external or internal cardioversion may result in maintaining sinus rhythm long-term in patients with refractory AF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423954     DOI: 10.1161/01.cir.86.5.1415

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

Review 1.  New devices and hybrid therapies and new devices for treatment of atrial fibrillation.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements.

Authors:  G L Botto; A Politi; W Bonini; T Broffoni; R Bonatti
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

3.  Successful external cardioversion of atrial fibrillation in patients referred to an electrophysiologist for internal cardioversion.

Authors:  R J Verdino; J J Teuteberg; M C Burke; D E Kopp; C T Johnson; A C Lin; M Alberts; J G Kall; D J Wilber
Journal:  Clin Cardiol       Date:  2001-07       Impact factor: 2.882

4.  Transvenous low energy internal cardioversion for atrial fibrillation refractory to external cardioversion: do non-obese patients benefit?

Authors:  D Pavin; H Legrand; C Leclercq; C Crocq; P Mabo; J C Daubert
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

5.  eHEART: www.heartjnl.com.

Authors: 
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

6.  Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.

Authors:  H F Tse; C P Lau; G M Ayers
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

7.  Transvenous cardioversion of atrial fibrillation using low-energy shocks.

Authors:  A G Socas; P Ricard; V Taramasco; M Guenoun; S Lévy
Journal:  J Interv Card Electrophysiol       Date:  1997-09       Impact factor: 1.900

8.  Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation.

Authors:  K E Paravolidakis; T M Kolettis; G N Theodorakis; I A Paraskevaidis; T S Apostolou; D T Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  1998-09       Impact factor: 1.900

Review 9.  Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint.

Authors:  S Lévy
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 10.  Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.

Authors:  Gerald V Naccarelli; John Hynes; Deborah L Wolbrette; Luna Bhatta; Mazhar Khan; Jerry Luck
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.